Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Tofacitinib may help treat hair loss in children with alopecia areata.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Deucravacitinib helped a man regrow hair significantly.

Deucravacitinib helped a man regrow hair and improve psoriasis.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib is an effective treatment for severe alopecia areata.

Rivaroxaban may cause hair loss.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

BMS-470539 reduces skin fibrosis and inflammation.